课题基金 / 基金详情

Peri-pancreatic Lymphatics : Evaluation with 3. 0T MR imaging(fat-suppressed T2-weighted images with a three-dimensional spectral pre-saturation with inversion recovery volume isotropic turbo spin echo acquisition)

Peri-pancreatic Lymphatics : Evaluation with 3. 0T MR imaging(fat-suppressed T2-weighted images with a three-dimensional spectral pre-saturation with inversion recovery volume isotropic turbo spin echo acquisition)
胰周淋巴管:使用 3. 0T MR 成像进行评估(脂肪抑制 T2 加权图像,具有三维光谱预饱和,具有反转恢复体积各向同性涡轮自旋回波采集)
批准号:
21591568
负责人:
MORI Hiromu
金额:
$2.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

MORI Hiromu的其他基金

相似基金

相关文献

中文摘要
翻译
目的对腹骨盆淋巴管的详细解剖研究仅在尸体上进行。胰胆管淋巴管的磁共振成像尚未见报道。本研究的目的是评估正常胰胆管淋巴的可视性。0-T MR成像。材料与方法对27例怀疑为肝脏或胰胆管疾病,经病理诊断为良性病变的患者进行回顾性分析。G,肝囊肿,肝血管瘤)被评估为胰胆管淋巴正常的受试者。磁共振成像方案包括脂肪抑制的t2加权图像,三维光谱预饱和,反演恢复体积各向同性涡轮自旋回波采集(SPIR VISTA)。胰头及肝十二指肠韧带周围淋巴管分为8段,便于图像解释。每个部分的可见性由2名观察员根据预先定义的标准在5点置信度上独立评估。通过Kappa统计评估观察者间的一致性。最后的意见是一致通过的。结果各节段的显像率分别为:前上段显像率100%,前中段显像率89%,前下段显像率85%,后上、中、下段及乳糜动脉与肠系膜上动脉之间右侧显像率100%,肝十二指肠韧带周围显像率96%。观察员间达成了良好或优秀的协议。结论SPIR - VISTA三维脂肪抑制t2加权图像能充分显示正常情况下的胰胆管淋巴。
英文摘要
PurposeDetailed anatomy of abdominopelvic lymphatics has been studied only in cadavers. There is no report regarding the MR imaging of pancreatobiliary lymphatics. The purpose of this study was to assess the visibility of normal pancreatobiliary lymphatics on 3. 0-T MR imaging.Materials and MethodsTwenty-seven patients who were suspected of hepatic or pancreatobiliary diseases and diagnosed as benign pathologies(e. g., hepatic cysts, hepatic hemangioma) were evaluated as subjects having normal pancreatobiliary lymphatics. The MR imaging protocol consisted of fat-suppressed T2-weighted images with a three-dimensional spectral pre-saturation with inversion recovery volume isotropic turbo spin echo acquisition(SPIR VISTA). For image interpretation, the lymphatics surrounding the pancreatic head and hepatoduodenal ligament were divided into eight segments. Visibility of each segment was rated independently by 2 observers according to predefined criteria on a 5-point confidence scale. Interobserver agreement was assessed by Kappa statistics. The final opinion was reached by consensus.ResultsEach segment was visualized as follows : 100% of the anterior upper portion, 89% of the anterior middle portion, 85% of the anterior lower portion, 100% of the upper and middle to lower posterior portions as well as the right side portion between the celiac and superior mesenteric arteries, and 96% of the surrounding area of the hepatoduodenal ligament. Good or excellent interobserver agreement was determined.ConclusionPancreatobiliary lymphatics under normal conditions could be sufficiently visualized on fat-suppressed T2-weighted images with a three-dimensional SPIR VISTA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
膵癌の画像診断:最新のgenomics less-invasive therapyの知見に基いた画像診断戦略
胰腺癌的影像诊断:基于最新基因组学微创治疗发现的影像策略
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Yoshioka K、Tanaka R, 他2名, 森宣]
通讯作者: 森宣
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [清永麻紀, 才道昭, 香泉和寿, 山田康成, 松本俊郎, 森宣]
通讯作者: 森宣
IPMN由来と考えられた破骨細胞様巨細胞を伴った膵未分化癌の1例
胰腺未分化癌伴破骨细胞样巨细胞被认为源自 IPMN 的一例
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [高司亮, 山田康成, 松本俊郎, 本郷哲央, 森宣, 泥谷直樹, 守山正胤, 柴田浩平, 太田正之, 北野正剛]
通讯作者: 北野正剛
DOI: 10.1007/s00261-009-9579-7
发表时间: 2010-04-01
期刊: ABDOMINAL IMAGING
影响因子: --
作者: [Yamada, Yasunari, Mori, Hiromu, Hongo, Norio]
通讯作者: Hongo, Norio
38
    Clinical study of Percutaneous Interstitial Nd-YAG Laser Hyperthermia for the Treatment of Hepatocellular Carcinoma
    • 批准号:
      09670944
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      1997
    • 负责人:
      MORI Hiromu
    • 依托单位:
    CLINICAL SIGNIFICANCE OF UNEVEN FATTY REPLACEMENT OF THE PANCREAS
    • 批准号:
      07671019
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1995
    • 负责人:
      MORI Hiromu
    • 依托单位:
    海外基金